Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combinat (Q81608387)
Jump to navigation
Jump to search
scientific article published on 01 July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combinat |
scientific article published on 01 July 2008 |
Statements
Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate (English)
Hp Sennels
M Ostergaard
Ls Knudsen
Ms Hansen
H Skjødt
Nd Peters
A Colic